circGLS2 inhibits hepatocellular carcinoma recurrence via regulating hsa-miR-222-3p-PTEN-AKT signaling

Signal Transduct Target Ther. 2023 Feb 17;8(1):67. doi: 10.1038/s41392-022-01275-6.

Authors

Xi Chen^#¹, Ting Wu^#¹, Linfeng Xian^#¹, Longteng Ma^#¹, Nan Li², Wenbin Liu¹, Peng Cai¹, Xiaojie Tan¹, Jianhua Yin³, Guangwen Cao⁴

Affiliations

¹ Department of Epidemiology, Second Military Medical University, Shanghai, China.
² Department of Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
³ Department of Epidemiology, Second Military Medical University, Shanghai, China. hawkyjh163@163.com.
⁴ Department of Epidemiology, Second Military Medical University, Shanghai, China. gcao@smmu.edu.cn.

^# Contributed equally.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Carcinoma, Hepatocellular* / genetics
Carcinoma, Hepatocellular* / pathology
Humans
Liver Neoplasms* / genetics
Liver Neoplasms* / pathology
MicroRNAs* / genetics
PTEN Phosphohydrolase / genetics
PTEN Phosphohydrolase / metabolism
Proto-Oncogene Proteins c-akt / genetics
Proto-Oncogene Proteins c-akt / metabolism
Signal Transduction / genetics

Substances

Proto-Oncogene Proteins c-akt
MicroRNAs
PTEN protein, human
PTEN Phosphohydrolase
MIRN222 microRNA, human